Saikesaisi Holding Group Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
299
- Latest Deal Type
-
IPO
- (Cancelled)
- Financing Rounds
-
6
- Investments
-
1
Saikesaisi Holding Group General Information
Description
Developer and manufacturer of absorbable medical devices and implantable materials designed for neurosurgery, cardiovascular surgery, and general surgical applications. The company utilizes proprietary technology platforms for PEG functionalization, bio-based polymers, and self-assembling peptides to produce absorbable dural sealants, vascular sealants, and hemostatic powders, enabling clinical professionals to achieve effective wound closure, prevent post-operative adhesions, and improve patient recovery outcomes.
Contact Information
Website
www.successbio-tech.comCorporate Office
- No. 2222, Kaituo Road
- Innovation Zone
- Jinan, Shandong 250101
- China
Corporate Office
- No. 2222, Kaituo Road
- Innovation Zone
- Jinan, Shandong 250101
- China
Saikesaisi Holding Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Saikesaisi Holding Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Saikesaisi Holding Group Patents
Saikesaisi Holding Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025030604-A1 | Cross-linked amniotic membrane material, and preparation method therefor and use thereof | Inactive | 10-Aug-2023 | ||
| AU-2024205144-B1 | Crosslinked amniotic membrane material, preparation method therefore, and applications thereof | Active | 10-Aug-2023 | ||
| AU-2023237194-B1 | Self-assembling peptides and applications thereof | Active | 16-Mar-2023 | ||
| EP-4610271-A1 | Self-assembling polypeptide and use thereof | Active | 16-Mar-2023 | ||
| EP-4610271-A4 | Self-assembling polypeptide and use thereof | Active | 16-Mar-2023 | C07K7/08 |
Saikesaisi Holding Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Saikesaisi Holding Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Saikesaisi Holding Group Investments (1)
Saikesaisi Holding Group’s most recent deal was a Corporate with Sysine. The deal was made on 23-Jan-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sysine | 23-Jan-2007 | Corporate | Alternative Energy Equipment |
Saikesaisi Holding Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sysine | Jinan, China | 2007 |
Saikesaisi Holding Group FAQs
-
When was Saikesaisi Holding Group founded?
Saikesaisi Holding Group was founded in 2003.
-
Where is Saikesaisi Holding Group headquartered?
Saikesaisi Holding Group is headquartered in Jinan, China.
-
What is the size of Saikesaisi Holding Group?
Saikesaisi Holding Group has 299 total employees.
-
What industry is Saikesaisi Holding Group in?
Saikesaisi Holding Group’s primary industry is Surgical Devices.
-
Is Saikesaisi Holding Group a private or public company?
Saikesaisi Holding Group is a Private company.
-
What is Saikesaisi Holding Group’s current revenue?
The current revenue for Saikesaisi Holding Group is .
-
How much funding has Saikesaisi Holding Group raised over time?
Saikesaisi Holding Group has raised $17.1M.
-
Who are Saikesaisi Holding Group’s investors?
Guoxing Investment, Shandong Development and Investment Group, Shanghai Wangying Investment Management, and Shandong Shunning Fund Management have invested in Saikesaisi Holding Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
